The 41,000 sq ft facility will be utilized to manufacture clinical to commercial-grade peptide products for increased manufacturing capacity
This new €59 million, 70,000 square foot facility, officially opened today, brings 50 new jobs to the area
63-year old woman gets rare Transcatheter Tricuspid Valve Replacement (TTVR)
Site has a capital investment program of ~$30 million spent or committed over the last three years to expand capabilities and improve operational efficiencies
During the research term, Olema will contribute funding to Aurigene to facilitate ongoing discovery efforts.
RH Capital, a leading women's health venture capital fund, announced three new investments to improve health outcomes for women in the US.
The partnership between Lockwood and Random42 expands the capabilities and geographic footprint for both organizations.
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
It is part of the company's CAD $30 million capital investment in the Aurora, Canada site
Revolutionary ovarian cancer rapid test available Q4 2022
Subscribe To Our Newsletter & Stay Updated
